JPM vs PLUT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
PLUT presents a stark contrast between a stable balance sheet and catastrophic operational performance. While the Piotroski F-Score of 5/9 indicates stable financial health and the company maintains high liquidity (Current Ratio 6.29) with negligible debt, these are overshadowed by a -196.19% profit margin and a severe -47.70% YoY revenue decline. The technical trend is completely bearish (0/100), and the company is significantly underperforming its sector peers in both growth and profitability.
Compare Another Pair
Related Comparisons
JPM vs PLUT: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Plutus Financial Group Limited (PLUT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.